Biosimilars offer real cost savings on expensive biologic drugs, with up to 85% discounts on list prices. Yet most spending still goes to originators due to rebate systems and slow adoption. Learn how much you could save and why competition isn’t moving faster.
View More
MAOIs are powerful antidepressants for treatment-resistant depression, but they come with strict dietary rules and dangerous drug interactions. Learn what you need to know before considering them.
View More
Parkinson’s disease causes tremor, stiffness, and movement problems due to dopamine loss. Dopamine replacement with levodopa helps manage symptoms but doesn’t cure the disease. Long-term use can lead to side effects, requiring careful timing and personalized treatment.
View More
Learn how to manage dry eyes caused by medications using lubricants and humidifiers. Compare OTC and prescription options, understand real user experiences, and discover practical steps for relief.
View More
Probiotics can be dangerous for people on immunosuppressants. Learn who’s at risk, which strains to avoid, and what safer alternatives exist for managing gut health without triggering life-threatening infections.
View More
Lithium is effective for bipolar disorder but dangerous when combined with common drugs like diuretics and NSAIDs. Learn how these interactions raise toxicity risk and what steps to take to stay safe.
View More
Dairy can block up to 92% of certain antibiotics from being absorbed. Learn which ones are affected, how long to wait, and what to avoid to make sure your treatment works.
View More
Compare Geriforte with top adaptogenic alternatives like ashwagandha, Rhodiola, and Relora for stress and energy support. See which one actually works based on science and real-world use.
View More
Red-green color blindness is a genetic condition affecting 8% of men and 0.5% of women. Learn how it's inherited, how it affects daily life, and what tools and technologies help people adapt.
View More
Tentative approval from the FDA means a generic drug is scientifically ready-but not legally allowed to sell. Common delays include patent lawsuits, slow paperwork, manufacturing issues, and profit-driven market decisions. Here’s why these drugs sit on the shelf.
View More